Business highlights Agreement to license the marketing and distribution rights of ChondroCelect to Sobi, a leading European specialty pharmaceutical company dedicated to niche disease indications, signed in April Agreement to sell the Dutch manufacturing facility to PharmaCell for a total consideration of for Cx601 technology transfer ongoing ... (more)
http://ift.tt/1uXYLkf
http://ift.tt/1uXYLkf
No comments:
Post a Comment